FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to pharmacological formulation used for prevention and treatment of diabetes, containing at least one agent stimulating insulin secretion and at least one inhibitor of FBP-ase, selected of composition formulations I and IA
.
EFFECT: improved therapeutic efficiency.
142 cl, 2 dwg, 21 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINATION OF INHIBITORS OF FBP-ASE AND SENSITIZING AGENTS OF INSULIN FOR DIABETES MELLITUS TREATMENT | 1999 |
|
RU2227749C2 |
BISAMIDATE PHOSPHONATE COMPOUNDS AS INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE | 2000 |
|
RU2273642C2 |
NEW HETERO-AROMATIC INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHOTASE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD OF INHIBITING FRUCTOSE-1,6-BISPHOSPHOTASE | 1999 |
|
RU2327700C2 |
PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING AND USING | 2006 |
|
RU2303597C1 |
LIGANDS OF 5-HT RECEPTORS, PHARMACEUTICAL FORMULATION, PRODUCTION METHOD AND MEDICAL PRODUCT | 2006 |
|
RU2329044C1 |
COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
METHODS AND COMPOSITIONS IMPROVING PATIENT'S TOLERANCE OF MYOCARDIAL VISUALISATION TECHNIQUE | 2007 |
|
RU2459626C2 |
1-OXO-3-(1H-INDOL-3-YL)-1,2,3,4-TETRAHYDROISOQUINOLINES, METHODS OF PREPARATION THEREOF, COMBINATORY LIBRARY, AND FOCUSED LIBRARY | 2006 |
|
RU2302417C1 |
N-HYDROXYLSULPHONAMIDE DERIVATIVES AS NOVEL PHYSIOLOGICALLY USEFUL NITROXYL DONORS | 2008 |
|
RU2485097C2 |
MODIFIED 2- AND 3-NUCLEOSIDES AND USE THEREOF TO PRODUCE MEDICINAL AGENT, HAVING HEPATITIS C INHIBITING ACTIVITY | 2003 |
|
RU2437892C2 |
Authors
Dates
2008-07-10—Published
2001-07-05—Filed